Association between anti-Chlamydia trachomatis antibody and ectopic pregnancy at the Federal Medical Centre, Umuahia, Abia State.
Mbamba CC1*, Nduka EC1, Agwu F1, Kalu E2, Okwara CE1
1Department of Obstetrics and Gynaecology, Federal Medical Centre, Umuahia, Abia State, Nigeria.
2Department of Microbiology, Federal Medical Centre, Umuahia, Abia State, Nigeria.
*Correspondence: Dr. Mbamba C. Charles; +234 803 340 8592; email@example.com
Download full article in pdf format
Background: The rise in the incidence of ectopic pregnancies is partly attributed to the increase in pelvic infection rates. Pelvic inﬂammatory disease (PID) is the most important cause of tubo-peritoneal damage and subsequent reproductive morbidity. Chlamydia trachomatis (CT) is the commonest bacterial sexually transmitted infection worldwide and has been found to be the commonest cause of salpingitis and PID.
Objective: To determine the association between prior Chlamydia trachomatis infection and the development of ectopic pregnancy.
Materials and method: This was a hospital-based case-control study in which 43 women with diagnosis of ectopic pregnancy conﬁrmed at laparotomy and also with the histology of extirpated specimen (cases) and another 43 with uncomplicated intrauterine pregnancy matched for maternal age (controls) were recruited. Structured interviewer-guided questionnaire was utilized to extract relevant data. Venous blood sample was taken from each woman for quantitative anti-Chlamydia trachomatis IgG antibody titres using an automated photometer. Data was analysed using SPSS version 20.
Results: A positive IgG antibody index seen in 62.8% of the case arm was signiﬁcantly higher than 23.3% in the controls (p<0.000). The mean titre in those who were positive was also higher in the case arm. The Population attributable risk percent (PAR%) was 46%. Furthermore, the association between CT infection and ectopic pregnancy was sustained when the socio-demographic characteristics and sexual and reproductive factors were controlled for. Signiﬁcant risk factors for ectopic pregnancy include being single (OR 32.82 CI 2.97- 362.75), early age at sexual debut (OR 4.65; CI 1.28-16.11) and a positive history of induced abortion (OR 2.06; CI 0.78-5.38).
Conclusion: Chlamydia trachomatis causes tubo-peritoneal damage which can predispose to ectopic pregnancy. A protocol for screening and prevention should be drawn for reproductive age women.
Key words: Chlamydia trachomatis, Pelvic inﬂammatory disease, Ectopic pregnancy.
Cite this article: Mbamba CC, Nduka EC, Agwu F, Kalu E, Okwara CE. Association between anti-Chlamydia trachomatis antibody and ectopic pregnancy at the Federal Medical Centre, Umuahia, Abia State. Yen Med J. 2020;2(1):105–118.
- Igwegbe AO, Eleje GU, Okpala BG. An appraisal of the management of ectopic pregnancy in a Nigerian Tertiary Hospital. Ann Med Health Sci Res. 2013;3(2):166-170.
- Adewunmi AA, Orekoya OO, Rabiu KA, Ottun TA. The association between Chlamydia trachomatis and ectopic pregnancy in Lagos, Nigeria – a case-control study. Open J Obstet Gynecol. 2015;5:112-122.
- O’Connel CM, Ferone ME. Chlamydia trachomatis genital infections. Microb Cell. 2016;3(9):390-403. Doi:10.15698/mic2016.09.525.
- Ogbu GI, Anzaku SA, Aimakhu C. Burden of Chlamydia trachomatis infection amongst infertile women compared with pregnant controls in North-central Nigeria. Int J Res Med Sci. 2017;5(9):3819-3826.
- Witkins SS, Minnis E, Athanasious A, Leiser J, Linhaves Im. Chlamydia trachomatis: the persistent pathogen. Clin Vaccine Immunol. 2017;24:e20203-17. Available from: https://doi.org/10.1128/cvi.00203-17. Accessed November 24, 2019.
- Jurkovic D. Ectopic pregnancy: In: Edmunds DK, ed. Dewhurst’s Textbook of Obstetrics and Gynaecology. 8th ed. London, UK: Wiley Blackwell; 2012:76-87.
- Panti A, Nwobodo EI, Omokanye Ol, Ahmed Y, Shehu CE, Tanko BA. Ectopic pregnancy at Usman Danfodio University Teaching Hospital, Sokoto: a 10-year review. Ann Nig Med. 2012;6:87-91.
- Centre for disease control and prevention (CDC). Recommendations for laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae. MMWR. 2014;63(2):1-19.
- Centre for Disease Control and Prevention (CDC), Division of STDs prevention, National Centre for HIV/AIDs, viral hepatitis, STD and TB prevention. CDC STD treatment guidelines, 2015. Available from: https://www.cdc.gov/mmwr/pdf/rr/rr6403.pdf. Accessed November 24, 2019.
- World Health Organisation. Guidelines for the treatment of Chlamydia trachomatis. Geneva: WHO; 2016. Available from: https://apps.who.int/iris/bitstream/handle/10665/246165/9789241549714eng.pdf;jsessionid=5E4966A2EC592CDF7CBB8A335821B234?sequence=1. Accessed September 20, 2017.
- Malhatra M, Said S, Mukherjee A, Muralidha S, Bala M. Genital Chlamydia trachomatis: an update. Indian J Med Res. 2013;138:303-316.
- Miller KE. Diagnosis and treatment of Chlamydia trachomatis Am Fam Phy. 2006;73:1411-1416.
- Adegbesan-Omilabu MA, Okunade KS, Oluwole AA, Gbadegesin A, Omilabu SA. Chlamydia trachomatis among women with normal and abnormal cervical smears in Lagos, Nigeria. Int J Reprod Contracept Obstet Gynecol. 2014;3(3):501-506.
- Agholor K, Omo-Aghoja L, Okonofua F. Association of anti-chlamydia antibodies with ectopic pregnancy in Benin City, Nigeria: a case-control study. Afr Health Sci. 2013;13(2):430-440.
- Ibe VC, Jeremiah I, Ikeanyi E. Chlamydia trachomatis infection: Serological evidence in women with ectopic pregnancy in Portharcourt. Int STD Res Rev. 2016;4(3):1-9. doi 10.9734/ISRR/2016/27420.
- Moses AO, Munirdeen AI, Adegboyega FA, Abdulgafar JA. A study of serological evidence of prior Chlamydia trachomatis infection in patients with ectopic pregnancy in Ilorin. Nig Eur J Sci Res. 2007;16(2):461-466.
- Benjamin MA, Yaakub R, Pam M, Yusuf J, Osman O. Role of Chlamydia infection in ectopic pregnancy. Brunei Int Med J. 2013;9(2):97-101.
- Mpiima DP, Salongo GW, Lugobe H, Ssemujju A, Mulisya M, Masinda A, et al. Association between prior Chlamydia trachomatis infection and Ectopic pregnancy at a tertiary care hospital in South Western Uganda. Obstet Gynecol Int. 2018;(2018):4827353. https://doi.org/10.1155/2018/4827353. Accessed September 28, 2017.
- Ahmad FF, Brown JK, Campbell LL, Koscielniak M, Oliver C, Wheelhouse N, et al. pelvic chlamydial infection predisposes to ectopic pregnancy by upgrading Integrin β1 to promote tubal attachment. Ebiomedicine. 2018;29:159-165. Doi: 10.1016/j.ebiom.2018.02.020.
- Hoenderbrown BM, van Ess EF, van der Brook IVF, van Loo IHM, Hoebe CJPA, Ouburg S, et al. Chlamydia trachomatis antibody detection in home-collected blood samples for use in epidemiological studies. J Microbiol Methods. 2018;144:164-167.
- Anderson B, Ostergaard L, Putro E, Skriver MV, Schonheyder HC. Ectopic pregnancy and reproductive capacity after Chlamydia trachomatis positive and results: A histological follow-up. Sex Trans Dis. 2005;32:377-381.
- Hornung S, Thuong BC, Beghdadi CK. The role of Chlamydia trachomatis and emerging chlamydia-related bacteria in ectopic pregnancy in Vietnam. Epidem Inf. 2015;143(12):2635-2638.
- Bakken TJ, Skjeldestael FE, Nordbo SA. Chlamydia trachomatis infection and the increased risk for ectopic pregnancy: a population-based nested case-control study. Sex Trans Dis. 2007;34(3):166-169.
- Vandenbroucke JP, Pearce N. Case-control studies: basic concepts. Int J Epidemiol. 2012;41(5):1480-1489.
- Calculating and interpreting attributable risk and population attributable risk. FHOP Planning guide. Available from: https://fhop.ucsf.edu/sites/fhop.ucsf.edu/files/wysiwyg/pg_apxIIIB.pdf. Accessed December 21, 2019.
- Bokhari H, Shahid I, Rasheed F, Hayat A. Anti-chlamydial antibodies in women with ectopic pregnancy. J Rawalpindi Med Coll. 2017;3:215-218.
- World Health Organisation. Global incidence and prevalence of selected STDs: Overview and estimates. Geneva: WHO; 2011. Available from: https://apps.who.int›iris›bitstream›9789241503839_eng. Accessed July 17, 2017.
- Tina R, Pairi JK, Erika W, Hanna O, Aini B, Matti L, et al. Population-based study of prediagnostic antibodies to Chlamydia trachomatis in relation to adverse pregnancy outcome. Sex Trans Dis. 2016;43(6):382-387.
- Fernández-Huerta M, Espasa M. Mycoplasma genitaliumco-infection with Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic patients: the silent wick for macrolide resistance spread. Sex Transm Infect. 2019;95(5):391-398. doi: 10.1136/sextrans-2018-053848.
- Black CM, Current methods for the laboratory diagnosis of Chlamydia trachomatis Clin Microbiol Rev. 1997;10:160-84.
- Akande VA, Hunt LP, Cahil DJ. Tubal damage in infertile women: Prediction using chlamydia serology. Human Reprod. 2003;18:1841-47. Available from: http://doi.org/10.1093/humrep/deg347. Accessed July 20, 2017.
- Shoukri M, Donner A, Al-Mohanna F. Estimation of attributable risk from a clustered binary data: the case of cross-sectional and cohort studies. Open J Stat. 2017;7:240-253.
- Gowitz RJ, Wiesenfield HC, Chen PL, Hammond KR, Sereday KA, Haggerty CL. Population attributable fraction of tubal factor infertility associated with Chlamydia. Am J Obstet Gynecol. 2017;217:3:336e1-336e16.
- Mansournia MA Altman DG. Population attributable fraction. British Med J. 2018;360-367. Doi.org/10.1136/bmj.12757.
- Oriji PC, Kiridi K, Allagoa DO, Omietimi JE, Orisabinone IB, Makinde OI. et al. Pattern of tubal pathology in infertile women undergoing hysterosalpingography at the Federal Medical Centre, Yenagoa, Bayelsa State, Nigeria. Yen Med J. Forthcoming 2020 Jan;2(1).
- Stephens AJ, Aubuchon M, Schust DJ. Antichlamydial antibodies, Human fertility and Pregnancy wastage. Inf Dis Obstet Gynecol. 2011;(2011):525182. Available from: https://dx.doi.org/10.1155/2011/525182. Assessed September 18, 2017.
- Horrigan MW, Haugan SE. The declining middle-class thesis: a sensitivity analysis. Monthly Lab Rev.1988;3-13.
- Oriji PC, Kiridi KE, Allagoa DO, Omietimi JE, Orisabinone IB, Makinde OI, et al. The use of NAAT-PCR to determine asymptomatic chlamydia and gonorrhoea infections in infertile patients undergoing hysterosalpingogram at the federal medical centre, Yenagoa, South-South Nigeria. Int J Reprod Contracept Obstet Gynecol. Forthcoming 2020 April;9(4)